Back to search

Boston University

The role of GLP-1 receptor agonists in the obesity pandemic

Abstract

dc:description.abstract

Overweight (BMI greater than 25 kg/m^2) and obese (BMI greater than 30 kg/m^2), along with their comorbidities, affect an increasing proportion of the world. Obesity and its pathologies not only decrease lifespan but also decrease quality of life. In the last century, access to food, particularly unhealthy food, has gone well beyond what would be found in humanity's ancient environment. In a society where the environment has changed rapidly, in dissent with human evolution, the question of how to treat the obesity pandemic is pressing. This paper will discuss how the United States reached approximately 70% of adults being overweight and obese, evaluate the attempted pharmacological interventions, and discover what the newest pharmacological advancement, GLP-1 receptor agonists, has to teach scientists about obesity pathology and intervention.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Paldrmic, Isabella
Advisor dc:contributor.advisor
  • Offner, Gwynneth

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51807

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Paldrmic, Isabella. The role of GLP-1 receptor agonists in the obesity pandemic. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51807